Zura Bio Ltd (ZURA) — 8-K Filings

8-K Filings (47)

• 8-K Filing — May 7, 2026
• 8-K Filing — Dec 17, 2025
• Zura Bio Ltd. Announces Director and Officer Changes — Oct 10, 2025 Risk: low
  Zura Bio Ltd. announced on October 8, 2025, changes related to its board of directors and officers, including the election of new directors and the appointment
• Zura Bio Ltd. Files 8-K: Board Changes and Financials — Sep 30, 2025 Risk: medium
  Zura Bio Ltd. announced on September 24, 2025, a change in its board of directors and executive compensation arrangements. The filing also includes financial st
• Zura Bio Ltd. to Acquire Subsidiaries — Sep 4, 2025 Risk: medium
  Zura Bio Ltd. announced on September 4, 2025, that it has entered into a definitive agreement to acquire all outstanding shares of certain subsidiaries of a pri
• Zura Bio Ltd. Files 8-K on Warrants — Aug 20, 2025 Risk: low
  Zura Bio Ltd. filed an 8-K on August 20, 2025, reporting on warrants. The filing details information related to the company's warrants, which are financial inst
• Zura Bio Ltd. Files 8-K on Operations and Financials — Aug 14, 2025 Risk: low
  Zura Bio Ltd. filed an 8-K on August 14, 2025, reporting on its results of operations and financial condition. The filing also includes financial statements and
• Zura Bio Appoints New CMO, Elects Director — Jul 1, 2025 Risk: medium
  Zura Bio Ltd. announced on June 25, 2025, the appointment of Dr. Priya Kumar as Chief Medical Officer and the election of Mr. David Chen to its Board of Directo
• Zura Bio Ltd. Files 8-K with Financials and Exhibits — Jun 4, 2025 Risk: low
  Zura Bio Ltd. filed an 8-K on June 4, 2025, reporting on financial statements and exhibits. The company, formerly JATT Acquisition Corp, is incorporated in the
• Zura Bio Ltd. Files 8-K on Warrants — May 27, 2025 Risk: low
  Zura Bio Ltd. filed an 8-K on May 27, 2025, reporting on warrants. The filing indicates that the company, previously known as JATT Acquisition Corp until April
• Zura Bio Ltd. Files 8-K on Security Holder Votes — May 23, 2025 Risk: low
  Zura Bio Ltd. filed an 8-K on May 23, 2025, reporting on matters submitted to a vote of security holders as of May 21, 2025. The filing indicates Zura Bio Limit
• Zura Bio Ltd. Files 8-K: Regulation FD & Financials — May 20, 2025 Risk: low
  Zura Bio Ltd. filed an 8-K on May 20, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly JATT Acquisition C
• Zura Bio Ltd. Files 8-K on Operations and Financials — May 8, 2025 Risk: low
  Zura Bio Ltd. filed an 8-K on May 8, 2025, reporting on its results of operations and financial condition, as well as financial statements and exhibits. The com
• Zura Bio Ltd. Enters Material Definitive Agreement on Warrants — Apr 17, 2025 Risk: medium
  On April 16, 2025, Zura Bio Ltd. entered into a material definitive agreement related to warrants. The company, formerly known as JATT Acquisition Corp., is inc
• Zura Bio Ltd. Files 8-K on Operations and Financials — Mar 25, 2025 Risk: low
  Zura Bio Ltd. filed an 8-K on March 25, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhib
• Zura Bio Completes Merger with Liminal BioSciences — Feb 24, 2025 Risk: medium
  Zura Bio Ltd. announced on February 24, 2025, the closing of its previously announced business combination with Liminal BioSciences Inc. This transaction result
• Monte Rosa to Acquire Zura Bio for $1.7B — Jan 13, 2025 Risk: medium
  Zura Bio Ltd. announced on January 13, 2025, that it has entered into a definitive agreement to be acquired by Monte Rosa Therapeutics, Inc. The transaction is
• Zura Bio Acquires Takeda Assets for $100M+ — Dec 23, 2024 Risk: medium
  Zura Bio Ltd. announced on December 23, 2024, that it has entered into a definitive agreement to acquire certain assets from Takeda Pharmaceutical Company Limit
• Zura Bio Acquires ADC Platform Assets — Nov 25, 2024 Risk: medium
  Zura Bio Ltd. announced on November 25, 2024, that it has entered into a definitive agreement to acquire certain assets related to the development of a novel an
• Zura Bio Ltd. Files 8-K on Financials — Nov 7, 2024 Risk: low
  Zura Bio Ltd. filed an 8-K on November 7, 2024, reporting on its results of operations and financial condition, as well as financial statements and exhibits. Th
• Zura Bio Ltd. Files 8-K with Financials and Exhibits — Oct 30, 2024 Risk: low
  Zura Bio Ltd. filed an 8-K on October 30, 2024, reporting on financial statements and exhibits. The company, previously known as JATT Acquisition Corp. until Ap
• Zura Bio Ltd. to be Acquired by 03 Life Sciences — Oct 29, 2024 Risk: medium
  Zura Bio Ltd. announced on October 23, 2024, that it has entered into a definitive agreement to be acquired by 03 Life Sciences. The transaction is expected to
• Zura Bio Appoints New CEO, CFO, and Directors — Oct 18, 2024 Risk: medium
  Zura Bio Ltd. announced on October 15, 2024, a significant change in its leadership structure. The company elected three new directors: Dr. Jonathan Lim, Dr. Da
• Zura Bio to Acquire Assets, Expanding Pipeline — Sep 9, 2024 Risk: medium
  Zura Bio Ltd. announced on September 9, 2024, that it has entered into a definitive agreement to acquire certain assets from an undisclosed seller. The transact
• Zura Bio Ltd. Files 8-K: Regulation FD & Financials — Sep 3, 2024 Risk: low
  Zura Bio Ltd. filed an 8-K on September 3, 2024, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly JATT Acquisit
• Zura Bio Ltd. Files 8-K for Material Definitive Agreement — Aug 21, 2024 Risk: medium
  On August 15, 2024, Zura Bio Ltd. entered into a material definitive agreement related to unregistered sales of equity securities. The filing also includes fina
• Zura Bio Ltd. Files 8-K with Financials and Exhibits — Aug 14, 2024 Risk: low
  Zura Bio Ltd. announced on August 14, 2024, a Regulation FD Disclosure and the filing of Financial Statements and Exhibits. The company, formerly JATT Acquisiti
• Zura Bio Ltd. Files 8-K on Operations and Financials — Aug 13, 2024 Risk: low
  Zura Bio Ltd. filed an 8-K on August 13, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and exhi
• Zura Bio Ltd. Files 8-K: Material Agreement & Shareholder Vote — Aug 12, 2024 Risk: medium
  On August 12, 2024, Zura Bio Ltd. entered into a Material Definitive Agreement, the details of which are not fully disclosed in this filing but relate to a subm
• Zura Bio Completes Business Combination, Raises $100M — Aug 9, 2024 Risk: medium
  On August 9, 2024, Zura Bio Ltd. filed an 8-K report detailing the completion of its business combination with JATT Acquisition Corp. The company also announced
• Zura Bio Appoints New CMO, Elects Directors — Jul 25, 2024 Risk: medium
  Zura Bio Ltd. announced on July 24, 2024, the appointment of Dr. Joshua Kazer as Chief Medical Officer and the election of Dr. Kazer and Ms. Sarah K. Kelly to i
• Zura Bio Completes Merger with Limelight Bio — Jul 12, 2024 Risk: medium
  On July 12, 2024, Zura Bio Ltd. filed an 8-K report detailing the closing of its business combination with Limelight Bio, Inc. The transaction, which was previo
• Zura Bio Ltd. Relocates Principal Executive Offices — Jun 14, 2024 Risk: low
  Zura Bio Ltd. filed an 8-K on June 14, 2024, reporting a change in its principal executive offices to Henderson, NV. The company, formerly JATT Acquisition Corp
• Zura Bio Ltd. Files 8-K with Financials and Exhibits — Jun 6, 2024 Risk: low
  Zura Bio Ltd. announced on June 6, 2024, a Regulation FD Disclosure and the filing of Financial Statements and Exhibits. The company, formerly JATT Acquisition
• Zura Bio to Acquire GigaGen for $100M — Jun 3, 2024 Risk: medium
  Zura Bio Ltd. announced on June 3, 2024, that it has entered into a definitive agreement to acquire all outstanding shares of equity interests in GigaGen Inc. f
• Zura Bio Acquires Cellarity Assets — May 29, 2024 Risk: medium
  Zura Bio Ltd. announced on May 29, 2024, that it has entered into a definitive agreement to acquire certain assets from Cellarity Limited. The transaction is ex
• Zura Bio Ltd. Files 8-K on Operations and Financials — May 9, 2024 Risk: low
  Zura Bio Ltd. filed an 8-K on May 9, 2024, reporting on its results of operations and financial condition, as well as financial statements and exhibits. The com
• Zura Bio Ltd. Files 8-K for Material Definitive Agreement — Apr 23, 2024 Risk: medium
  Zura Bio Ltd. entered into a Material Definitive Agreement on April 18, 2024, related to unregistered sales of equity securities. The company, formerly JATT Acq
• Zura Bio Ltd. Announces Asset Acquisition — Apr 8, 2024 Risk: medium
  Zura Bio Ltd. announced on April 8, 2024, that it has entered into a definitive agreement to acquire certain assets from a third party. The company did not disc
• Zura Bio Acquires Global Rights to ZOLINZA from Takeda — Mar 28, 2024 Risk: medium
  Zura Bio Ltd. announced on March 24, 2024, that it has entered into a definitive agreement to acquire certain assets from Takeda Pharmaceutical Company Limited.
• Zura Bio Ltd. Files 8-K: Regulation FD Disclosure & Exhibits — Mar 11, 2024 Risk: low
  On March 11, 2024, Zura Bio Ltd. filed an 8-K report detailing a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly JATT Acqu
• Zura Bio Ltd. Files 8-K — Mar 4, 2024 Risk: low
  Zura Bio Ltd. (formerly JATT Acquisition Corp.) filed an 8-K on March 4, 2024, reporting on its business and financial status. The company, incorporated in the
• Zura Bio Ltd. Changes Certifying Accountant Effective March 29, 2023 — Feb 23, 2024 Risk: low
  Zura Bio Ltd. filed an 8-K on February 23, 2024, reporting a change in its certifying accountant effective March 29, 2023. The company, formerly JATT Acquisitio
• Zura Bio Updates Principal Executive Offices and Contact Info — Feb 2, 2024
  Zura Bio Ltd. filed an 8-K on February 2, 2024, to update its principal executive offices to 1489 W. Warm Springs Rd. #110, Henderson, NV 89014, and its telepho
• Zura Bio Relocates Principal Executive Offices to Henderson, NV — Jan 11, 2024
  Zura Bio Ltd. filed an 8-K on January 11, 2024, to update its principal executive offices from La Jolla, CA to 1489 W. Warm Springs Rd. #110, Henderson, Nevada
• Zura Bio Relocates Principal Executive Offices to Henderson, NV — Jan 8, 2024
  Zura Bio Ltd. filed an 8-K on January 8, 2024, reporting a change in its principal executive offices from La Jolla, CA to 1489 W. Warm Springs Rd. #110, Henders
• Zura Bio Relocates HQ to Henderson, NV; Updates Contact Info — Jan 3, 2024
  Zura Bio Ltd. filed an 8-K on January 3, 2024, to update its principal executive offices to 1489 W. Warm Springs Rd. #110, Henderson, Nevada 89014, from its pre

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX